Cadila Healthcare - 4QFY20 Result - Angel Broking

Mr. Jyoti Roy, DVP Equity Strategist, Angel Broking Ltd

"Cadila Healthcare Ltd. has reported a 0.5% YoY growth in revenues to Rs. 3,752.1 crore for Q4FY20, while net profit for the quarter was down by 14.1% YoY to Rs. 413.7 crore. EBITDA margin for the quarter was down by 60 basis points to 21.1%. The company's numbers were impacted during the quarter to the extent of Rs. 45.2 crore due to impairment of goodwill for one of its subsidiary companies. Total exceptional loss for the quarter stood at Rs. 52.5 crore. Net profit for the year FY20 down by 36.3% YoY to Rs. 1,176.6 Crore. During the year the company filled 30 ANDAs in FY2020, taking cumulative filling to 390 ANDAs. The company also received 28 ANDA approvals during the year, taking total product approvals to 282."

Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.361.95 as compared to the previous close of Rs. 365.6. The total number of shares traded during the day was 312469 in over 4236 trades.

The stock hit an intraday high of Rs. 370 and intraday low of 360.35. The net turnover during the day was Rs. 113653122.

Source : Equity Bulls

Keywords